The Nippon India Pharma Fund - Growth has an AUM of 7637.04 crores & has delivered CAGR of 27.43% in the last 5 years. The fund has an exit load of 1.00% and an expense ratio of 1.82%. The minimum ...
The collaboration, which is reportedly a first of its kind in southern India, aims to equip students with smart manufacturing ...
The Trump administration's decision to exempt tariffs on Indian pharma imports brings relief to a $9 billion-plus US export market, highlighting India's key role in providing affordable generic ...
19 小时
Asian News International on MSNSpirit of Indian Constitution is to treat all citizens equally: Om Birla at 150th assembly ...Lok Sabha Speaker Om Birla on Sunday highlighted the inclusive and welfarist nature of the Constitution of India, mentioning ...
9 小时on MSN
Indian Army had announced the online registration process for the recruitment of Agniveers under the Agnipath Scheme 2025 ...
AI generated image India's pharma sector has emerged as a big winner amid Trump’s tariff woes, as the US has exempted pharmaceuticals from reciprocal tariffs, recognizing the vital role of India ...
The US market accounts for 30% of overall exports for India’s pharma sector. The industry welcomed the decision, saying that it underscores the critical role of cost-effective, life-saving generic ...
Prime Minister Narendra Modi announced several India-led initiatives at the Bimstec summit in Bangkok, targeting disaster ...
US president Donald Trump exempted imports of pharmaceuticals, energy and certain minerals in his “reciprocal tariffs” on Thursday, likely providing reprieve to India’s generic medicines industry.
Dr. Reddy’s Laboratories Ltd., Sun Pharma Ltd. Reciprocal tariffs for more than 60 countries, including India, the European Union, China, Vietnam, among others were announced by Trump.
As every pharma company invests in digital technology ... we are overlooking the potential of such techniques for internal training. The way in which we communicate has changed radically over ...
Ashish Rishi discusses the benefits of synchronous online learning for pharma, providing some tips on how to ensure the ROI on training is measurable. In our increasingly global marketplace ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果